Literature DB >> 29440587

Association between acute respiratory disease events and the MUC5B promoter polymorphism in smokers.

Samuel Y Ash1, Rola Harmouche2, Rachel K Putman1, James C Ross2, Fernando J Martinez3, Augustine M Choi3, Russell P Bowler4, Elizabeth A Regan5, Jeffrey L Curtis6,7, MeiLan K Han6, Richard C Boucher8, Wanda K O'Neal8, Hiroto Hatabu9, David A Lynch10, Ivan O Rosas1, Gary M Hunninghake1, Raul San Jose Estepar2, George R Washko1.   

Abstract

A single-nucleotide polymorphism (rs35705950) in the mucin 5B (MUC5B) gene promoter is associated with pulmonary fibrosis and interstitial features on chest CT but may also have beneficial effects. In non-Hispanic whites in the COPDGene cohort with interstitial features (n=454), the MUC5B promoter polymorphism was associated with a 61% lower odds of a prospectively reported acute respiratory disease event (P=0.001), a longer time-to-first event (HR=0.57; P=0.006) and 40% fewer events (P=0.016). The MUC5B promoter polymorphism may have a beneficial effect on the risk of acute respiratory disease events in smokers with interstitial CT features. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  copd exacerbations; idiopathic pulmonary fibrosis; interstitial fibrosis

Mesh:

Substances:

Year:  2018        PMID: 29440587      PMCID: PMC6089672          DOI: 10.1136/thoraxjnl-2017-211208

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  10 in total

1.  Illustrating bias due to conditioning on a collider.

Authors:  Stephen R Cole; Robert W Platt; Enrique F Schisterman; Haitao Chu; Daniel Westreich; David Richardson; Charles Poole
Journal:  Int J Epidemiol       Date:  2009-11-19       Impact factor: 7.196

2.  Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers.

Authors:  Samuel Y Ash; Rola Harmouche; Rachel K Putman; James C Ross; Alejandro A Diaz; Gary M Hunninghake; Jorge Onieva Onieva; Fernando J Martinez; Augustine M Choi; David A Lynch; Hiroto Hatabu; Ivan O Rosas; Raul San Jose Estepar; George R Washko
Journal:  Chest       Date:  2017-05-12       Impact factor: 9.410

3.  Airway Mucin Concentration as a Marker of Chronic Bronchitis.

Authors:  Mehmet Kesimer; Amina A Ford; Agathe Ceppe; Giorgia Radicioni; Rui Cao; C William Davis; Claire M Doerschuk; Neil E Alexis; Wayne H Anderson; Ashley G Henderson; R Graham Barr; Eugene R Bleecker; Stephanie A Christenson; Christopher B Cooper; MeiLan K Han; Nadia N Hansel; Annette T Hastie; Eric A Hoffman; Richard E Kanner; Fernando Martinez; Robert Paine; Prescott G Woodruff; Wanda K O'Neal; Richard C Boucher
Journal:  N Engl J Med       Date:  2017-09-07       Impact factor: 91.245

4.  Muc5b is required for airway defence.

Authors:  Michelle G Roy; Alessandra Livraghi-Butrico; Ashley A Fletcher; Melissa M McElwee; Scott E Evans; Ryan M Boerner; Samantha N Alexander; Lindsey K Bellinghausen; Alfred S Song; Youlia M Petrova; Michael J Tuvim; Roberto Adachi; Irlanda Romo; Andrea S Bordt; M Gabriela Bowden; Joseph H Sisson; Prescott G Woodruff; David J Thornton; Karine Rousseau; Maria M De la Garza; Seyed J Moghaddam; Harry Karmouty-Quintana; Michael R Blackburn; Scott M Drouin; C William Davis; Kristy A Terrell; Barbara R Grubb; Wanda K O'Neal; Sonia C Flores; Adela Cota-Gomez; Catherine A Lozupone; Jody M Donnelly; Alan M Watson; Corinne E Hennessy; Rebecca C Keith; Ivana V Yang; Lea Barthel; Peter M Henson; William J Janssen; David A Schwartz; Richard C Boucher; Burton F Dickey; Christopher M Evans
Journal:  Nature       Date:  2013-12-08       Impact factor: 49.962

5.  A common MUC5B promoter polymorphism and pulmonary fibrosis.

Authors:  Max A Seibold; Anastasia L Wise; Marcy C Speer; Mark P Steele; Kevin K Brown; James E Loyd; Tasha E Fingerlin; Weiming Zhang; Gunnar Gudmundsson; Steve D Groshong; Christopher M Evans; Stavros Garantziotis; Kenneth B Adler; Burton F Dickey; Roland M du Bois; Ivana V Yang; Aretha Herron; Dolly Kervitsky; Janet L Talbert; Cheryl Markin; Joungjoa Park; Anne L Crews; Susan H Slifer; Scott Auerbach; Michelle G Roy; Jia Lin; Corinne E Hennessy; Marvin I Schwarz; David A Schwartz
Journal:  N Engl J Med       Date:  2011-04-21       Impact factor: 91.245

6.  Epithelial tethering of MUC5AC-rich mucus impairs mucociliary transport in asthma.

Authors:  Luke R Bonser; Lorna Zlock; Walter Finkbeiner; David J Erle
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

Review 7.  Structure and function of the polymeric mucins in airways mucus.

Authors:  David J Thornton; Karine Rousseau; Michael A McGuckin
Journal:  Annu Rev Physiol       Date:  2008       Impact factor: 19.318

8.  Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.

Authors:  Anna L Peljto; Yingze Zhang; Tasha E Fingerlin; Shwu-Fan Ma; Joe G N Garcia; Thomas J Richards; Lori J Silveira; Kathleen O Lindell; Mark P Steele; James E Loyd; Kevin F Gibson; Max A Seibold; Kevin K Brown; Janet L Talbert; Cheryl Markin; Karl Kossen; Scott D Seiwert; Elissa Murphy; Imre Noth; Marvin I Schwarz; Naftali Kaminski; David A Schwartz
Journal:  JAMA       Date:  2013-06-05       Impact factor: 56.272

9.  MUC5B promoter polymorphism and interstitial lung abnormalities.

Authors:  Gary M Hunninghake; Hiroto Hatabu; Yuka Okajima; Wei Gao; Josée Dupuis; Jeanne C Latourelle; Mizuki Nishino; Tetsuro Araki; Oscar E Zazueta; Sila Kurugol; James C Ross; Raúl San José Estépar; Elissa Murphy; Mark P Steele; James E Loyd; Marvin I Schwarz; Tasha E Fingerlin; Ivan O Rosas; George R Washko; George T O'Connor; David A Schwartz
Journal:  N Engl J Med       Date:  2013-05-21       Impact factor: 91.245

10.  Prediction of acute respiratory disease in current and former smokers with and without COPD.

Authors:  Russell P Bowler; Victor Kim; Elizabeth Regan; André A A Williams; Stephanie A Santorico; Barry J Make; David A Lynch; John E Hokanson; George R Washko; Peter Bercz; Xavier Soler; Nathaniel Marchetti; Gerard J Criner; Joe Ramsdell; MeiLan K Han; Dawn Demeo; Antonio Anzueto; Alejandro Comellas; James D Crapo; Mark Dransfield; J Michael Wells; Craig P Hersh; Neil MacIntyre; Fernando Martinez; Hrudaya P Nath; Dennis Niewoehner; Frank Sciurba; Amir Sharafkhaneh; Edwin K Silverman; Edwin J R van Beek; Carla Wilson; Christine Wendt; Robert A Wise
Journal:  Chest       Date:  2014-10       Impact factor: 9.410

  10 in total
  2 in total

1.  MUC5B Promoter Polymorphism and Development of Acute Respiratory Distress Syndrome.

Authors:  Angela J Rogers; Joseph F Solus; Gary M Hunninghake; Rebecca M Baron; Nuala J Meyer; David R Janz; David A Schwartz; Addison K May; William E Lawson; Timothy S Blackwell; Lorraine B Ware
Journal:  Am J Respir Crit Care Med       Date:  2018-11-15       Impact factor: 21.405

2.  Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Gonzalo Vegas Sanchez-Ferrero; Farbod N Rahaghi; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie Pistenmaa Aaron; Alejandro A Diaz; James C Ross; Michael J Cuttica; Wassim W Labaki; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.